Thomas Graney
Direktor/Vorstandsmitglied bei Mogrify Ltd.
Vermögen: 38 637 $ am 30.04.2024
Aktive Positionen von Thomas Graney
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Mogrify Ltd.
 Mogrify Ltd. BiotechnologyHealth Technology Mogrify Ltd. engages in the development of direct cellular conversion technology. It applies its technology to generate internet protocol and cell types that will power the development and manufacture of new cell therapies in any therapeutic area. The company was founded by Julian Gough, Owen John Llewellyn Rackham, and Jose Polo in 2009 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 02.11.2021 | - |
Karriereverlauf von Thomas Graney
Ehemalige bekannte Positionen von Thomas Graney
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OXURION NV | Direktor/Vorstandsmitglied | - | 28.12.2023 |
| Vorstandsvorsitzender | 17.05.2021 | 28.12.2023 | |
| Finanzdirektor/CFO | 14.10.2020 | - | |
| AC IMMUNE SA | Direktor/Vorstandsmitglied | 15.11.2016 | 01.01.2023 |
| Independent Dir/Board Member | 15.11.2016 | 01.01.2023 | |
| VERTEX PHARMACEUTICALS INCORPORATED | Finanzdirektor/CFO | 13.09.2017 | 13.12.2018 |
| IRONWOOD PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 02.09.2014 | 13.09.2017 |
Ethicon, Inc.
 Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Finanzdirektor/CFO | 01.01.2010 | 01.08.2014 |
| Tibotec Pharmaceuticals | Finanzdirektor/CFO | 01.11.2005 | 01.02.2008 |
| GENERATION BIO CO. | Finanzdirektor/CFO | 18.12.2018 | - |
Ausbildung von Thomas Graney
| University of Delaware | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 7 |
| Schweiz | 2 |
| Irland | 2 |
Operativ
| Director of Finance/CFO | 6 |
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| AC IMMUNE SA | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| GENERATION BIO CO. | Health Technology |
| OXURION NV | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Ethicon, Inc.
Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Health Technology |
| Tibotec Pharmaceuticals | |
Mogrify Ltd.
Mogrify Ltd. BiotechnologyHealth Technology Mogrify Ltd. engages in the development of direct cellular conversion technology. It applies its technology to generate internet protocol and cell types that will power the development and manufacture of new cell therapies in any therapeutic area. The company was founded by Julian Gough, Owen John Llewellyn Rackham, and Jose Polo in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Thomas Graney
- Erfahrung
